Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.
Rizzuto GA; Merghoub T; Hirschhorn-Cymerman D; Liu C; Lesokhin AM; Sahawneh D; Zhong H; Panageas KS; Perales MA; Altan-Bonnet G; Wolchok JD; Houghton AN; The Journal Of Experimental Medicine, 2009, vol. 206, issue 4, p 849, ISSN 15409538. ISBN 15409538.
Full Text Resources Located for this Citation